Results 61 to 70 of about 5,602,030 (205)
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma
Journal for ImmunoTherapy of Cancer, 2020 Background A pilot study of stereotactic body radiation therapy (SBRT) followed by high-dose interleukin-2 (IL-2) showed a higher than anticipated objective response rate (ORR) among patients with metastatic melanoma (MM).Marka Crittenden, Brendan Curti, Walter J Urba, Roxanne Payne, Steven K Seung, Christopher B Fountain, ShuChing Chang, Jessica Fleser, Kimberly Phillips, Ian Malkasian, Lyn B Dobrunick +10 moredoaj +1 more sourcePB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES
HemaSphere, 2023 Adam Olszewski, David Kahn, Brian Yoo, Zhe Nie, Goran Krilov, Joanne Tan, Hamish Wright, Daniel Weiss, Wu Yin, Karen Akinsanya +9 moredoaj +1 more sourceNucleosomes indicate the in vitro radiosensitivity of irradiated bronchoepithelial and lung cancer cells [PDF]
, 2004 Nucleosomes, which are typical cell death products, are elevated in the serum of cancer patients and are known to rapidly increase during radiotherapy.Al-Batran SE, Albrecht Bergner, Anke Mitlewski, Bepler G, Bergner A, Dorothea Nagel, Fernando Gamarra, Jutta Stief, Kerr JF, Kuroi K, Petra Stieber, Rudolph M. Huber, Stefan Holdenrieder, Szumiel I, Wyllie AH +14 morecore +1 more sourceT057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume
HemaSphere, 2022 Ryan C. Lynch, Stefan Alig, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Andrei Shustov, Brian Till, Vikram M. Raghunathan, Yolanda Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Sarith Keo, Kaitlin Verni, Hongyan Du, Jackie Vandermeer, Ashley Gaston, Heather Rasmussen, Avanti Gulhane, Delphine L. Chen, Paul Martin, Edmond Marzbani, Jenna Voutsinas, Ash A. Alizadeh, Ajay K. Gopal +26 moredoaj +1 more sourceTwo Cases of Ectopic Hamartomatous Thymoma Masquerading as Sarcoma
Case Reports in Otolaryngology, 2017 Ectopic hamartomatous thymoma (EHT) is an extremely rare benign tumor. EHTs are difficult to differentiate from sarcomas, especially synovial sarcomas. We encountered two cases of EHT that were referred from other hospitals because sarcoma was suspected. Takahito Kondo, Yukiko Sato, Hiroko Tanaka, Toru Sasaki, Kazuyoshi Kawabata, Hiroki Mitani, Hiroyuki Yonekawa, Hirofumi Fukushima, Wataru Shimbashi +8 moredoaj +1 more sourceDo changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data. [PDF]
, 2019 Background and objectiveEarly detection methods for pancreatic cancer are lacking. We aimed to develop a prediction model for pancreatic cancer based on changes in health captured by healthcare claims data.MethodsWe conducted a case-control study on 29 ...Baecker, Aileen, Hendifar, Andrew E, Jeon, Christie Y, Kim, Sungjin, Nuckols, Teryl K, Pandol, Stephen J, Pisegna, Joseph R, Risch, Harvey A, Wu, Bechien U +8 morecore +2 more sourcesToward optimal implementation of cancer prevention and control programs in public health: A study protocol on mis-implementation [PDF]
, 2018 Background Much of the cancer burden in the USA is preventable, through application of existing knowledge. State-level funders and public health practitioners are in ideal positions to affect programs and policies related to cancer control.A McGowan, A Strauss, A Strauss, AA Vincus, AH Mokdad, AJR Carter, AL Harris, American Cancer Society, B Rabin, BA Rabin, BA Rabin, Benjamin Heuberger, BH Forsyth, BY Lee, C Maylahn, CE Basch, D Ciliska, D Dillman, D Gnjidic, D Luke, D Pourshaban, DA Luke, DA Marshall, DE Gibbons, Doug A. Luke, E Bonabeau, E Bruch, E Hennessy, E Larsen, EA Dodson, EM Rogers, G Dunn, G Fioretti, GA Aarons, GA Colditz, GM Higginbottom, Institute of Medicine, J Epstein, J Harrison, J-O Kim, JA Jacobs, JA Jacobs, JB Jobe, JB Jobe, JG Burke, JH Miller, JR Landis, KA Bollen, L Elliott, L Kohn, L Rychetnik, L Yarber, LA Curry, LW Green, M Dobbins, M Dreisinger, M Huhman, M Maclure, MA O’Neall, MA Pett, MA Sanchez, MA Sastry, Margaret Padek, Matt Kasman, Melissa Franco, MQ Patton, ND Kohatsu, P Allen, P Ballew, P Brewer Gad, P Drehobl, P Ellis, P Gagne, P Glasziou, P Noriega, PA Briss, PA Hannon, Paul C. Erwin, PC Erwin, Peg Allen, PS Hovmand, PW Rochester, RA Hammond, RA Nianogo, RB Gunderman, RC Brownson, RC Brownson, RC Brownson, RC Brownson, RC Brownson, RC Brownson, RC Brownson, Ross A. Hammond, Ross C. Brownson, RR Jacob, RR Massatti, S Feirman, S Kreitner, S Kumar, Sarah Moreland-Russell, SL West, ST Brown, Stephanie Mazzucca, T Byers, TK Boehmer, V Prasad, WC Willett, WS Gibbert +107 morecore +2 more sourcesInfection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study
Infectious Agents and Cancer, 2016 Background The incidence of hepatocellular carcinoma (HCC) and its association with hepatitis C (HCV) and hepatitis B virus (HBV) infections, FIB-4 index and liver enzymes was assessed in an area of the province of Naples covered by a population-based ...Mario Fusco, Pierluca Piselli, Saverio Virdone, Pietro Di Cicco, Paola Scognamiglio, Paolo De Paoli, Valerio Ciullo, Diana Verdirosi, Michele D’Orazio, Luigino Dal Maso, Enrico Girardi, Silvia Franceschi, Diego Serraino +12 moredoaj +1 more source